Herpesvirus Entry Mediator HVEM Mediates Cell-Cell Spread in BHK(TK(−)) Cell Clones

Por Roller, Richard J., Rauch, Daniel
Publicado em 1998

Targeting HTLV-1 Activation of NFκB in Mouse Models and ATLL Patients

Por Rauch, Daniel A., Ratner, Lee
Publicado em 2011

The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30-II mRNA

Por Choudhary, Gunjan, Rauch, Daniel, Ratner, Lee
Publicado em 2011

Mutations in Herpes Simplex Virus Glycoprotein D Distinguish Entry of Free Virus from Cell-Cell Spread

Por Rauch, Daniel A., Rodriguez, Nilda, Roller, Richard J.
Publicado em 2000

Tet-inducible lymphoma in a new Tax transgenic mouse model

Por Rauch, Daniel, Bokhari, Sirosh, Harding, John, Ratner, Lee
Publicado em 2011

IL-15 deficiency promotes tumor growth in tax transgenic mice

Por Rauch, Daniel, Bokhari, Sirosh, Harding, John, Ratner, Lee
Publicado em 2011

The effects of XMRV gene expression on the mouse prostate

Por Rauch, Daniel, Bokhari, Sirosh, Harding, John, Ratner, Lee
Publicado em 2011

IL-15 Deficient Tax Mice Reveal a Role for IL-1α in Tumor Immunity

Por Rauch, Daniel A., Harding, John C., Ratner, Lee
Publicado em 2014

IL-15 deficient Tax mice reveal a role for IL-1α in tumor immunity

Por Rauch, Daniel A, Harding, John C, Ratner, Lee
Publicado em 2014

Cholesterol Dependence of HTLV-I Infection

Por WIELGOSZ, MATTHEW M., RAUCH, DANIEL A., JONES, KATHRYN S., RUSCETTI, FRANK W., RATNER, LEE
Publicado em 2005

Bioluminescence imaging of myeloperoxidase activity in vivo

Por Gross, Shimon, Gammon, Seth T, Moss, Britney L, Rauch, Daniel, Harding, John, Heinecke, Jay W, Ratner, Lee, Piwnica-Worms, David
Publicado em 2009

The Strategic Planning Committee Report: The First Step in a Journey to Recognize Pediatric Hospital Medicine as a Distinct Discipline

Por Maloney, Christopher G., Swanson Mendez, Suzanne, Quinonez, Ricardo A., Bode, Ryan S., Brands, Chad K., Eagle, Steven, Nena Osorio, Snezana, Rauch, Daniel, Simon, Tamara D.
Publicado em 2012

EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer

Por Baty, Florent, Rothschild, Sacha, Früh, Martin, Betticher, Daniel, Dröge, Cornelia, Cathomas, Richard, Rauch, Daniel, Gautschi, Oliver, Bubendorf, Lukas, Crowe, Susanne, Zappa, Francesco, Pless, Miklos, Brutsche, Martin
Publicado em 2013

Herpes Simplex Virus with Highly Reduced gD Levels Can Efficiently Enter and Spread between Human Keratinocytes

Por Huber, Mary T., Wisner, Todd W., Hegde, Nagendra R., Goldsmith, Kimberley A., Rauch, Daniel A., Roller, Richard J., Krummenacher, Claude, Eisenberg, Roselyn J., Cohen, Gary H., Johnson, David C.
Publicado em 2001

The ARF Tumor Suppressor Regulates Bone Remodeling and Osteosarcoma Development in Mice

Por Rauch, Daniel A., Hurchla, Michelle A., Harding, John C., Deng, Hongju, Shea, Lauren K., Eagleton, Mark C., Niewiesk, Stefan, Lairmore, Michael D., Piwnica-Worms, David, Rosol, Thomas J., Weber, Jason D., Ratner, Lee, Weilbaecher, Katherine N.
Publicado em 2010

Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03

Por Taverna, Christian, Martinelli, Giovanni, Hitz, Felicitas, Mingrone, Walter, Pabst, Thomas, Cevreska, Lidija, del Giglio, Auro, Vanazzi, Anna, Laszlo, Daniele, Raats, Johann, Rauch, Daniel, Vorobiof, Daniel A., Lohri, Andreas, Biaggi Rudolf, Christine, Rondeau, Stéphanie, Rusterholz, Corinne, Heijnen, Ingmar A.F.M., Zucca, Emanuele, Ghielmini, Michele
Publicado no J Clin Oncol (2016)

SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-neg...

Por Rochlitz, Christoph, Bigler, Martin, von Moos, Roger, Bernhard, Jürg, Matter-Walstra, Klazien, Wicki, Andreas, Zaman, Khalil, Anchisi, Sandro, Küng, Marc, Na, Kyung-Jae, Bärtschi, Daniela, Borner, Markus, Rordorf, Tamara, Rauch, Daniel, Müller, Andreas, Ruhstaller, Thomas, Vetter, Marcus, Trojan, Andreas, Hasler-Strub, Ursula, Cathomas, Richard, Winterhalder, Ralph
Publicado no BMC Cancer (2016)

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

Por Colleoni, Marco, Gray, Kathryn P., Gelber, Shari, Láng, István, Thürlimann, Beat, Gianni, Lorenzo, Abdi, Ehtesham A., Gomez, Henry L., Linderholm, Barbro K., Puglisi, Fabio, Tondini, Carlo, Kralidis, Elena, Eniu, Alexandru, Cagossi, Katia, Rauch, Daniel, Chirgwin, Jacquie, Gelber, Richard D., Regan, Meredith M., Coates, Alan S., Price, Karen N., Viale, Giuseppe, Goldhirsch, Aron
Publicado no J Clin Oncol (2016)